nodes	percent_of_prediction	percent_of_DWPC	metapath
Phylloquinone—BGLAP—forelimb zeugopod—peripheral nervous system neoplasm	0.196	0.398	CbGeAlD
Phylloquinone—BGLAP—skull—peripheral nervous system neoplasm	0.102	0.208	CbGeAlD
Phylloquinone—BGLAP—forelimb—peripheral nervous system neoplasm	0.0986	0.2	CbGeAlD
Phylloquinone—BGLAP—arm—peripheral nervous system neoplasm	0.0847	0.172	CbGeAlD
Phylloquinone—Cyanosis—Tretinoin—peripheral nervous system neoplasm	0.0126	0.0253	CcSEcCtD
Phylloquinone—Cyanosis—Isotretinoin—peripheral nervous system neoplasm	0.0126	0.0253	CcSEcCtD
Phylloquinone—GGCX—cerebellum—peripheral nervous system neoplasm	0.0111	0.0226	CbGeAlD
Phylloquinone—Hyperbilirubinaemia—Topotecan—peripheral nervous system neoplasm	0.00987	0.0198	CcSEcCtD
Phylloquinone—Cyanosis—Alitretinoin—peripheral nervous system neoplasm	0.00953	0.0192	CcSEcCtD
Phylloquinone—Necrosis—Dactinomycin—peripheral nervous system neoplasm	0.00927	0.0186	CcSEcCtD
Phylloquinone—Inflammation—Tretinoin—peripheral nervous system neoplasm	0.00918	0.0185	CcSEcCtD
Phylloquinone—Inflammation—Isotretinoin—peripheral nervous system neoplasm	0.00918	0.0185	CcSEcCtD
Phylloquinone—Injection site reaction—Isotretinoin—peripheral nervous system neoplasm	0.00885	0.0178	CcSEcCtD
Phylloquinone—Injection site reaction—Tretinoin—peripheral nervous system neoplasm	0.00885	0.0178	CcSEcCtD
Phylloquinone—Injection site reaction—Melphalan—peripheral nervous system neoplasm	0.00873	0.0176	CcSEcCtD
Phylloquinone—Phlebitis—Tretinoin—peripheral nervous system neoplasm	0.0075	0.0151	CcSEcCtD
Phylloquinone—Phlebitis—Isotretinoin—peripheral nervous system neoplasm	0.0075	0.0151	CcSEcCtD
Phylloquinone—Cyanosis—Etoposide—peripheral nervous system neoplasm	0.00744	0.015	CcSEcCtD
Phylloquinone—Swelling—Isotretinoin—peripheral nervous system neoplasm	0.00732	0.0147	CcSEcCtD
Phylloquinone—Swelling—Tretinoin—peripheral nervous system neoplasm	0.00732	0.0147	CcSEcCtD
Phylloquinone—Necrosis—Cisplatin—peripheral nervous system neoplasm	0.00732	0.0147	CcSEcCtD
Phylloquinone—Inflammation—Alitretinoin—peripheral nervous system neoplasm	0.00695	0.014	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Topotecan—peripheral nervous system neoplasm	0.00673	0.0135	CcSEcCtD
Phylloquinone—Necrosis—Etoposide—peripheral nervous system neoplasm	0.00671	0.0135	CcSEcCtD
Phylloquinone—Injection site reaction—Alitretinoin—peripheral nervous system neoplasm	0.00671	0.0135	CcSEcCtD
Phylloquinone—Phlebitis—Dactinomycin—peripheral nervous system neoplasm	0.00613	0.0123	CcSEcCtD
Phylloquinone—Phlebitis—Alitretinoin—peripheral nervous system neoplasm	0.00568	0.0114	CcSEcCtD
Phylloquinone—Swelling—Alitretinoin—peripheral nervous system neoplasm	0.00555	0.0112	CcSEcCtD
Phylloquinone—Sweating increased—Tretinoin—peripheral nervous system neoplasm	0.00544	0.0109	CcSEcCtD
Phylloquinone—Sweating increased—Isotretinoin—peripheral nervous system neoplasm	0.00544	0.0109	CcSEcCtD
Phylloquinone—Inflammation—Etoposide—peripheral nervous system neoplasm	0.00543	0.0109	CcSEcCtD
Phylloquinone—Phlebitis—Cisplatin—peripheral nervous system neoplasm	0.00484	0.00974	CcSEcCtD
Phylloquinone—Sweating—Topotecan—peripheral nervous system neoplasm	0.00481	0.00968	CcSEcCtD
Phylloquinone—Sweating—Tretinoin—peripheral nervous system neoplasm	0.00477	0.0096	CcSEcCtD
Phylloquinone—Sweating—Isotretinoin—peripheral nervous system neoplasm	0.00477	0.0096	CcSEcCtD
Phylloquinone—Phlebitis—Etoposide—peripheral nervous system neoplasm	0.00444	0.00892	CcSEcCtD
Phylloquinone—Swelling—Etoposide—peripheral nervous system neoplasm	0.00433	0.00871	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Cisplatin—peripheral nervous system neoplasm	0.00431	0.00867	CcSEcCtD
Phylloquinone—Flushing—Tretinoin—peripheral nervous system neoplasm	0.00415	0.00834	CcSEcCtD
Phylloquinone—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.00415	0.00834	CcSEcCtD
Phylloquinone—Sweating increased—Alitretinoin—peripheral nervous system neoplasm	0.00412	0.00829	CcSEcCtD
Phylloquinone—Flushing—Melphalan—peripheral nervous system neoplasm	0.00409	0.00824	CcSEcCtD
Phylloquinone—Immune system disorder—Topotecan—peripheral nervous system neoplasm	0.00407	0.00819	CcSEcCtD
Phylloquinone—Immune system disorder—Melphalan—peripheral nervous system neoplasm	0.00398	0.00802	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Etoposide—peripheral nervous system neoplasm	0.00395	0.00794	CcSEcCtD
Phylloquinone—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00389	0.00783	CcSEcCtD
Phylloquinone—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00389	0.00783	CcSEcCtD
Phylloquinone—Necrosis—Epirubicin—peripheral nervous system neoplasm	0.00376	0.00756	CcSEcCtD
Phylloquinone—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.00362	0.00728	CcSEcCtD
Phylloquinone—Injection site pain—Epirubicin—peripheral nervous system neoplasm	0.00361	0.00727	CcSEcCtD
Phylloquinone—Sweating increased—Cisplatin—peripheral nervous system neoplasm	0.00351	0.00706	CcSEcCtD
Phylloquinone—Sweating—Vincristine—peripheral nervous system neoplasm	0.00349	0.00701	CcSEcCtD
Phylloquinone—Necrosis—Doxorubicin—peripheral nervous system neoplasm	0.00348	0.007	CcSEcCtD
Phylloquinone—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.00339	0.00682	CcSEcCtD
Phylloquinone—Injection site pain—Doxorubicin—peripheral nervous system neoplasm	0.00334	0.00673	CcSEcCtD
Phylloquinone—Hyperbilirubinaemia—Epirubicin—peripheral nervous system neoplasm	0.00325	0.00653	CcSEcCtD
Phylloquinone—Sweating increased—Etoposide—peripheral nervous system neoplasm	0.00322	0.00647	CcSEcCtD
Phylloquinone—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.0032	0.00644	CcSEcCtD
Phylloquinone—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00318	0.0064	CcSEcCtD
Phylloquinone—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00318	0.00639	CcSEcCtD
Phylloquinone—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00318	0.00639	CcSEcCtD
Phylloquinone—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.00314	0.00632	CcSEcCtD
Phylloquinone—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00313	0.0063	CcSEcCtD
Phylloquinone—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00309	0.00622	CcSEcCtD
Phylloquinone—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00307	0.00617	CcSEcCtD
Phylloquinone—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00307	0.00617	CcSEcCtD
Phylloquinone—Inflammation—Epirubicin—peripheral nervous system neoplasm	0.00304	0.00612	CcSEcCtD
Phylloquinone—Hyperbilirubinaemia—Doxorubicin—peripheral nervous system neoplasm	0.003	0.00604	CcSEcCtD
Phylloquinone—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00297	0.00597	CcSEcCtD
Phylloquinone—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00297	0.00597	CcSEcCtD
Phylloquinone—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00295	0.00593	CcSEcCtD
Phylloquinone—Injection site reaction—Epirubicin—peripheral nervous system neoplasm	0.00293	0.0059	CcSEcCtD
Phylloquinone—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00293	0.00589	CcSEcCtD
Phylloquinone—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00285	0.00574	CcSEcCtD
Phylloquinone—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00283	0.00569	CcSEcCtD
Phylloquinone—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00283	0.00569	CcSEcCtD
Phylloquinone—Inflammation—Doxorubicin—peripheral nervous system neoplasm	0.00282	0.00566	CcSEcCtD
Phylloquinone—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00279	0.00562	CcSEcCtD
Phylloquinone—Pain—Topotecan—peripheral nervous system neoplasm	0.00274	0.00551	CcSEcCtD
Phylloquinone—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00272	0.00546	CcSEcCtD
Phylloquinone—Pain—Tretinoin—peripheral nervous system neoplasm	0.00272	0.00546	CcSEcCtD
Phylloquinone—Injection site reaction—Doxorubicin—peripheral nervous system neoplasm	0.00271	0.00546	CcSEcCtD
Phylloquinone—Pain—Melphalan—peripheral nervous system neoplasm	0.00268	0.00539	CcSEcCtD
Phylloquinone—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00268	0.00539	CcSEcCtD
Phylloquinone—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00261	0.00524	CcSEcCtD
Phylloquinone—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00251	0.00505	CcSEcCtD
Phylloquinone—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.00249	0.005	CcSEcCtD
Phylloquinone—Flushing—Etoposide—peripheral nervous system neoplasm	0.00245	0.00494	CcSEcCtD
Phylloquinone—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00241	0.00484	CcSEcCtD
Phylloquinone—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00239	0.0048	CcSEcCtD
Phylloquinone—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00236	0.00474	CcSEcCtD
Phylloquinone—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00234	0.00471	CcSEcCtD
Phylloquinone—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00234	0.00471	CcSEcCtD
Phylloquinone—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00233	0.00468	CcSEcCtD
Phylloquinone—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00232	0.00466	CcSEcCtD
Phylloquinone—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00231	0.00464	CcSEcCtD
Phylloquinone—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.0023	0.00463	CcSEcCtD
Phylloquinone—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00225	0.00452	CcSEcCtD
Phylloquinone—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00224	0.00451	CcSEcCtD
Phylloquinone—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00222	0.00446	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00221	0.00445	CcSEcCtD
Phylloquinone—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00217	0.00436	CcSEcCtD
Phylloquinone—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00215	0.00432	CcSEcCtD
Phylloquinone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00212	0.00426	CcSEcCtD
Phylloquinone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.0021	0.00422	CcSEcCtD
Phylloquinone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.0021	0.00422	CcSEcCtD
Phylloquinone—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00206	0.00414	CcSEcCtD
Phylloquinone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00205	0.00412	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00205	0.00412	CcSEcCtD
Phylloquinone—Pain—Vincristine—peripheral nervous system neoplasm	0.00198	0.00399	CcSEcCtD
Phylloquinone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00198	0.00399	CcSEcCtD
Phylloquinone—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00192	0.00385	CcSEcCtD
Phylloquinone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00191	0.00385	CcSEcCtD
Phylloquinone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00188	0.00378	CcSEcCtD
Phylloquinone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00183	0.00368	CcSEcCtD
Phylloquinone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00182	0.00365	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—SMARCB1—peripheral nervous system neoplasm	0.00178	0.183	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00177	0.00357	CcSEcCtD
Phylloquinone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00176	0.00353	CcSEcCtD
Phylloquinone—Pain—Cisplatin—peripheral nervous system neoplasm	0.00175	0.00353	CcSEcCtD
Phylloquinone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00171	0.00344	CcSEcCtD
Phylloquinone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00167	0.00337	CcSEcCtD
Phylloquinone—Pain—Etoposide—peripheral nervous system neoplasm	0.00161	0.00323	CcSEcCtD
Phylloquinone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.0032	CcSEcCtD
Phylloquinone—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00158	0.00318	CcSEcCtD
Phylloquinone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00153	0.00308	CcSEcCtD
Phylloquinone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00151	0.00304	CcSEcCtD
Phylloquinone—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.00146	0.00295	CcSEcCtD
Phylloquinone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00138	0.00278	CcSEcCtD
Phylloquinone—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00138	0.00277	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—NCAM1—peripheral nervous system neoplasm	0.00135	0.138	CbGpPWpGaD
Phylloquinone—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00134	0.00269	CcSEcCtD
Phylloquinone—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00129	0.0026	CcSEcCtD
Phylloquinone—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00256	CcSEcCtD
Phylloquinone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00124	0.0025	CcSEcCtD
Phylloquinone—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00249	CcSEcCtD
Phylloquinone—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.0024	CcSEcCtD
Phylloquinone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00212	CcSEcCtD
Phylloquinone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00205	CcSEcCtD
Phylloquinone—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000984	0.00198	CcSEcCtD
Phylloquinone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000974	0.00196	CcSEcCtD
Phylloquinone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000942	0.00189	CcSEcCtD
Phylloquinone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000939	0.00189	CcSEcCtD
Phylloquinone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00091	0.00183	CcSEcCtD
Phylloquinone—Pain—Epirubicin—peripheral nervous system neoplasm	0.0009	0.00181	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—BIRC5—peripheral nervous system neoplasm	0.000876	0.0899	CbGpPWpGaD
Phylloquinone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000869	0.00175	CcSEcCtD
Phylloquinone—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000833	0.00168	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—HGF—peripheral nervous system neoplasm	0.000817	0.0838	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000776	0.00156	CcSEcCtD
Phylloquinone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000718	0.00144	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.000702	0.0721	CbGpPWpGaD
Phylloquinone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000696	0.0014	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—peripheral nervous system neoplasm	0.000667	0.0684	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—MET—peripheral nervous system neoplasm	0.000644	0.0661	CbGpPWpGaD
Phylloquinone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000644	0.0013	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000596	0.0612	CbGpPWpGaD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—MET—peripheral nervous system neoplasm	0.000549	0.0563	CbGpPWpGaD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—CDKN2A—peripheral nervous system neoplasm	0.000419	0.0431	CbGpPWpGaD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000309	0.0317	CbGpPWpGaD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000273	0.028	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000231	0.0238	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—TP53—peripheral nervous system neoplasm	0.000196	0.0201	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000168	0.0172	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	0.000166	0.017	CbGpPWpGaD
